🇺🇸 FDA

Company profile · Sponsor

Ascentage

Ascentage Pharma Group

C47FF1E · NMPA pharma CN
Pipeline
2
Drugs
0
Patents
0

Quick answer

Ascentage (C47FF1E) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C47FF1E
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (2)

Search pipeline →

  1. Olverembatinib

    Ascentage

    Ph+ ALL

    phase 3 small molecule active

    1 trial

  2. Phase 1b: APG-115+pembrolizumab

    Ascentage

    Unresectable or Metastatic Melanoma or Advanced Solid Tumors

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Ascentage?

Ascentage (C47FF1E) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Ascentage sponsor?

We track 2 ClinicalTrials.gov-linked programs for Ascentage, including Olverembatinib and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Ascentage company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.